Level D· Scientific groundwork from lab and animal studiesAnimal StudyPubMed

Exosomes from adipose-derived stem cells preconditioned with 650- or 810-nm photobiomodulation enhance cutaneous wound healing in rats.

Amini A., Hashemi SM., Ahangari F., Bayat S., Tohidian M., Albright R.

Animal Study on Chronic Wound, published in Tissue Cell (2026) — summary generated from the PubMed abstract.

Open my reading list
Level D· Scientific groundwork from lab and animal studiesEvidence level of this study

Evidence from laboratory and animal studies provides groundwork for understanding mechanisms and potential before human studies continue.

  • Level A · Stronger Clinical Evidence
  • Level B · Emerging clinical evidence with positive signals
  • Level C · Early human research exploring benefits
  • Level D · Scientific groundwork from lab and animal studies
  • Emerging · Emerging topic under active research
Read the A–D evidence level guide

This page is generated from the PubMed record. The Thai description is an automated summary of bibliographic fields and the abstract, not a full translation, and is not medical advice.

Study type
Animal Study
Journal
Tissue Cell (2026)
Country
Scotland
Reported sample size
—
Source database
PubMed
PMID
42284729
DOI
10.1016/j.tice.2026.103690

Abstract (original English)

This study investigated whether photobiomodulation (PBM) preconditioning at 650 nm or 810 nm modifies the regenerative potential of exosomes secreted by human adipose-derived stem cells (HADSCs) during full-thickness acute skin wound healing in rats. Although both wavelengths have been shown to enhance ADSC viability, proliferation, and exosome release in vitro, their in vivo reparative efficacy remains incompletely defined. We had 4 groups: untreated controls, animals treated with exosomes from non-preconditioned HADSCs, and two groups receiving exosomes derived from HADSCs exposed to either 650-nm or 810-nm PBM. Exosomes were administered at a concentration of 150 μg/mL and a total dose of 450 μg per animal. Wound tissues were harvested on day 8 for biomechanical testing, stereological evaluation of tissue components, and analysis of miR-21, VEGF-A, and HIF-1α expression. The EXO 650, and EXO 810 groups demonstrated 119%, and 105% increases in Stress High Load capacity compared to control group (both p < 0.001). The EXO 650 and EXO 810 wavelengths resulted in 58% and 67% increase in fibroblast population (p < 0.01, p < 0.001). EXO 650 and EXO 810 wavelengths showed 43%, and 64% increases in the number of new blood vessels (p < 0.01, p < 0.001) over control values. Molecular signaling analysis via fold-change quantification indicates that Exo 650 and Exo 810 wavelengths achiev

What this study does not prove

  • • This study does not prove SVF is an approved treatment or a replacement for standard care.
  • • This is preclinical work; animal or laboratory results cannot be applied to humans.

Evidence level

Evidence from laboratory and animal studies provides groundwork for understanding mechanisms and potential before human studies continue.

How we grade evidence

Browse all related research

Filter the research library by this study's title keywords, author, or publication year.

Related research